tiprankstipranks
AbbVie (DE:4AB)
XETRA:4AB
Germany Market
Holding DE:4AB?
Track your performance easily

AbbVie (4AB) Technical Analysis

20 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting AbbVie is a Sell.
AbbVie’s (4AB) 20-Day exponential moving average is 167.51, while AbbVie’s (4AB) share price is €168.6, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 168.20, while AbbVie’s (4AB) share price is €168.6, making it a Buy.

AbbVie (4AB) Pivot Points

Jan 31, 2025, 11:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
164.87
165.87
167.79
168.79
170.71
171.71
173.63
Fibonacci
165.87
166.99
167.68
168.79
169.91
170.60
171.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Jan 31, 2025, 11:51 PM
Period
Simple
Exponential
MA5
167.41Buy
167.91Buy
MA10
166.37Buy
167.36Buy
MA20
168.31Buy
167.51Buy
MA50
167.39Buy
168.20Buy
MA100
170.36Sell
168.12Buy
MA200
163.67Buy
163.39Buy
AbbVie’s (4AB) 10-Day exponential moving average is 167.36, while AbbVie’s (4AB) share price is €168.6, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 168.12, while AbbVie’s (4AB) share price is €168.6, making it a Buy.
AbbVie’s (4AB) stock price is €168.6 and AbbVie’s (4AB) 50-day simple moving average is 167.39, creating a Buy signal.
AbbVie’s (4AB) stock price is €168.6 and AbbVie’s (4AB) 100-day simple moving average is 170.36, creating a Sell signal.
AbbVie’s (4AB) stock price is €168.6 and AbbVie’s (4AB) 200-day simple moving average is 163.67, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Jan 31, 2025, 11:51 PM
Name
Value
Implied Action
RSI (14)
52.08
Neutral
STOCH (9,6)
82.54
Sell
STOCHRSI (14)
60.80
Neutral
MACD (12,26)
-0.29
Sell
ADX (14)
14.28
Buy
Williams %R
-42.52
Buy
CCI (14)
-7.39
Neutral
ATR (14)
3.53
-
Ultimate Oscillator
50.36
Neutral
ROC
-1.30
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 52.08, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 14.28, creating a Buy signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -7.39, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -1.30, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 52.08, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is -0.29, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 167.41, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 168.31, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 167.39, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 163.67, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -42.52, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -7.39, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis